Your selection
Innovation / 24.06.2026
Eckert & Ziegler SE Annual General Meeting Approves Significantly Higher Dividend
The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of € 0.22 per share (previous year: € 0.17) for the 2025 fiscal year. As in previous years, the Annual General Meeting was held as an in-person event, right next to the Eckert & Ziegler SE headquarters in Berlin. In total, 55.37 % of the company’s share capital was represented. The Annual General Meeting endorsed the members of the Executive Board and the Supervisory Board of Eckert & Ziegler SE for the 2025 fiscal year and approved all items on the agenda by a large majority.
The detailed voting results of the Annual General Meeting and the CEO’s presentation are available on the Eckert & Ziegler SE website:
https://www.ezag.com/investors/annual-general-meeting/
About Eckert & Ziegler
Eckert & Ziegler SE with more than 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Contributing to saving lives.
Overview News
News Buch Berlin
Alithea Bio Scores Double Victory at VivaTech 2026 for Breakthrough in Preclinical Safety
Deep-tech biotech innovator Alithea Bio has achieved a spectacular double victory at VivaTech 2026, Europe’s largest startup and tech event, taking home both the coveted “Tech for Change” Jury Prize a...
more ...Eckert & Ziegler SE Annual General Meeting Approves Significantly Higher Dividend
The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of € 0.22 per share (previ...
more ...ERC Advanced Grants awarded to two Berlin researchers
Uwe Ohler and Gaetano Gargiulo have been awarded prestigious ERC Advanced Grants. With funding of €2.5 million each, they will spend the next five years investigating how protein synthesis is regulate...
more ...Events Buch Berlin
27.08.2026, 10:00
CRISPR/Cas: Grundlagen und praktische Anwendung (Verschoben vom 4. Juni auf 27. August)
Der Crashkurs für Einsteiger*innen vermittelt die Grundlagen der CRISPR/Cas Technologie. Die Teilnehmer*innen sollen in die Lage versetzt werden, CRISPR/Cas Experimente selbständig zu planen und durch...
more ...22.09.2026, 09:00
GMP Biotech Summer School
Knowing and applying the Good Manufacturing Practice (GMP) regulations is one of the key elements in the manufacture of medicinal products for clinical trials and on an industrial level.
more ...09.11.2026, 09:00
Fachkraft für Molekularbiologie
Elftägiges Intensivseminar der Berlin BioScience Academy. Es rmittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschu...
more ...